Guidelines for practical use of MAL-PDT in non-melanoma skin cancer

被引：74

作者：

Christensen, E. ^{[1
]}

Warloe, T. ^{[2
]}

Kroon, S. ^{[3
]}

Funk, J. ^{[4
]}

Helsing, P. ^{[5
]}

Soler, A. M. ^{[6
]}

Stang, H. J. ^{[7
]}

Vatne, O. ^{[8
]}

Mork, C. ^{[5
]}

机构：

[1] Norwegian Univ Sci & Technol, Dept Dermatol, St Olavs Univ Hosp HF, Inst Canc Res & Mol Med,Fac Med,NTNU, N-7034 Trondheim, Norway

[2] Oslo Univ Hosp, Rikshosp, Dept Surg, Oslo, Norway

[3] Stavanger Univ Hosp, Dept Dermatovenereol, Div Surg, Helse Stavanger HF, Stavanger, Norway

[4] Dr Funks Hudklin, Moss, Norway

[5] Oslo Univ Hosp, Rikshosp, Dept Dermatol, Oslo, Norway

[6] Oslo Univ Hosp, Photodynam Out Patients Clin, Dept Surg, Rikshosp,Aleris Med Ctr, Oslo, Norway

[7] Holdbergsplads Legesenter, Oslo, Norway

[8] Cent Hosp, Forde, Norway

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2010年 / 24卷 / 05期

关键词：

aminolaevulinic acid; guidelines; methyl aminolaevulinic acid; non-melanoma skin cancer; procedural PDT; topical photodynamic therapy; BASAL-CELL CARCINOMA; TOPICAL PHOTODYNAMIC THERAPY; METHYL AMINOLEVULINATE; 5-AMINOLEVULINIC ACID; ACTINIC KERATOSIS; DOUBLE-BLIND; BOWENS-DISEASE; PAIN RELIEF; TRANSPLANT RECIPIENTS; PROTOPORPHYRIN-IX;

D O I：

10.1111/j.1468-3083.2009.03430.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Methyl aminolaevulinate photodynamic therapy is increasingly practiced in the treatment of actinic keratoses, Bowen's disease and basal cell carcinomas. This method is particularly suitable for treating multiple lesions, field cancerization and lesions in areas where a good cosmetic outcome is of importance. Good treatment routines will contribute to a favourable result. The Norwegian photodynamic therapy (PDT) group consists of medical specialists with long and extensive PDT experience. With support in the literature, this group presents guidelines for the practical use of topical PDT in non-melanoma skin cancer.

引用

页码：505 / 512

页数：8

共 50 条

[31] Characteristics of patients with melanoma with non-melanoma skin cancer comorbidity: Practical implications based on a retrospective study
Slowinska, Monika
Czarnecka, Iwona
Czarnecki, Robert
Tatara, Paulina
Nasierowska-Guttmejer, Anna
Lorent, Malgorzata
Kania, Joanna
Owczarek, Witold
ONCOLOGY LETTERS, 2025, 29 (05)
[32] Dermoscopy in the diagnosis and management of non-melanoma skin cancers
Fargnoli, Maria Concetta
Kostaki, Dimitra
Piccioni, Antonella
Micantonio, Tamara
Peris, Ketty
EUROPEAN JOURNAL OF DERMATOLOGY, 2012, 22 (04) : 456 - 463
[33] Cetuximab in non-melanoma skin cancer
Wollina, Uwe
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (07) : 949 - 956
[34] Non-Melanoma Skin Cancer - Overview
Joseph, Kurian
CURRENT CANCER THERAPY REVIEWS, 2016, 12 (03) : 142 - 151
[35] Updates on the Management of Non-Melanoma Skin Cancer (NMSC)
Fahradyan, Artur
Howell, Anna C.
Wolfswinkel, Erik M.
Tsuha, Michaela
Sheth, Parthiv
Wong, Alex K.
HEALTHCARE, 2017, 5 (04)
[36] Non-Melanoma Skin Cancer Treatment Updates in the Elderly
Myers, Emma L.
Blasiak, Rachel C.
CURRENT GERIATRICS REPORTS, 2024, 13 (03) : 93 - 103
[37] Management of Non-melanoma Skin Cancer in Transplant Recipients
Collins, L.
Asfour, L.
Stephany, M.
Lear, J. T.
Stasko, T.
CLINICAL ONCOLOGY, 2019, 31 (11) : 779 - 788
[38] Non-melanoma skin cancer: Pathogenesis, prevalence and prevention
Zink A.
Der Hautarzt, 2017, 68 (11): : 919 - 928
[39] The role of radiotherapy in the management of non-melanoma skin cancer
Garbutcheon-Singh, Kieran B.
Veness, Michael J.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (04) : 265 - 272
[40] The Economic Impact of Non-Melanoma Skin Cancer: A Review
Mudigonda, Tejaswi
Pearce, Daniel J.
Yentzer, Brad A.
Williford, Phillip
Feldman, Steven R.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (08): : 888 - 896

← 1 2 3 4 5 →